The contrast to a unicorn startup is a workhorse. Hardly mythical, these businesses leverage the time-tested growth strategies of long-established companies by providing stellar quality service at ...

As a three-time founder, I’ve made this mistake more than once, and I’ve also seen other entrepreneurs make it too: Falling so in love with the big vision that we try to build the entire dream at ...

In a "Special Report" news interview in December 2023, Ukraine President Volodymyr Zelenskyy "begged Western leaders" to send all their money to Ukraine and told them, "Don't build roads, spend all of ...

You’ve heard it before and you’ll hear it again — college is hard. Deadlines and work pile up, clubs and sports take our evenings. To top it all off, there’s the pressure to find a picture-perfect ...

Gautam Gulati considers himself a shepherd of sorts, guiding homeowners through the booming wellness real estate industry. Gulati is the founder of the Well Home, an outfitter of wellness-focused ...

Standing in the Roman Pantheon last spring, one of my daughters asked the kind of question that newspaper columnists are tempted to place in the mouths of our children when we’re hard up for a column ...

Athletic Director John David Wicker and President Adela de la Torre: We gave it our best shot. I say that as an alumnus ...

The ghostly message whispered to Kevin Costner’s character in the movie “Field of Dreams” was clear – “If you build it, they will come.” It inspired Ray Kinsella to plow up a few acres of cornfields ...

Creating a successful app is not easy–it requires a mix of tech know-how, artistic skill, and marketing savvy. While some think this is better done in complete secrecy, or stealth mode, I could not ...

Let me be blunt: Most early-stage companies don’t need a CMO. At least not yet. I know that sounds like sacrilege in the startup world—where hiring a big-title marketing exec is often seen as the next ...

The Food and Drug Administration on Tuesday approved an osteoporosis drug that represents the first new treatment approach in nearly two decades — a strategy based on a rare gene mutation in people ...